Subcutaneous injection: difference between revisions
Diff·revision 13 → 14·18:27, 5 Jan 2025
Difference between revision 13 and revision 14 of Subcutaneous injection. 6 lines changed; the page grew by 115 bytes.
| Revision 13 — 23:06, 19 Dec 2024 HedgeHedda (talk) alphabetise the see-also list 3,730 bytes ±0 | Revision 14 — 18:27, 5 Jan 2025 GramsNotUnitsGil (talk) add the disclaimer that this is not administration guidance 3,845 bytes +115 | ||
|---|---|---|---|
| 38 | <ref name="usp1503">United States Pharmacopeia, General Chapter <1503>, ''Quality Attributes of Synthetic Peptide Drug Substances''.</ref> | 38 | <ref name="usp1503">United States Pharmacopeia, General Chapter <1503>, ''Quality Attributes of Synthetic Peptide Drug Substances''.</ref> |
| 39 | 39 | ||
| + | 40 | == See also == | |
| + | 41 | * [[Injection site rotation]] | |
| + | 42 | * [[Insulin syringe]] | |
| + | 43 | * [[Syringe dead space]] | |
| + | 44 | * [[Sharps disposal]] | |
| + | 45 | ||
| 40 | {{DEFAULTSORT:Subcutaneous injection}} | 46 | {{DEFAULTSORT:Subcutaneous injection}} |
| 41 | [[Category:Injection technique]] | 47 | [[Category:Injection technique]] |